"On November 18, 37-year-old José Garcia reached the finish line of the Bakersfield Marathon—but he didn’t cross alone. Before the end, Garcia went up to the sidelines to take hold of his 76-year-old mother-in-law, Odilia Esparza, who is battling late-stage Alzheimer’s disease, so she could finish the race with him."
Posts tagged as “AD”
"For nearly four years, John Jerome O’Hara took charge of his mother’s care at a Kentucky nursing home as Alzheimer’s disease robbed her of independence. O’Hara gained power of attorney over her affairs in June 2014 and was expected to manage thousands of dollars in income a month — and, perhaps most important, direct most of it for living expenses at Wesley Manor in Louisville."
"A new study has suggested that treating Alzheimer’s disease as six separate conditions could help forge the way for more personalized and effective treatments."
"The National Alzheimer's Project Act (NAPA) creates an important opportunity to build upon and leverage HHS programs and other federal efforts to help change the trajectory of Alzheimer's disease and related dementias (AD/ADRD). The law calls for a National Plan for AD/ADRD with input from a public-private Advisory Council on Alzheimer's Research, Care and Services. The Advisory Council makes recommendations to HHS for priority actions to expand, coordinate, and condense programs in order to improve the health outcomes of people with AD/ADRD and reduce the financial burden of these conditions on those with the diseases, their families, and society."
"InvestAcure, PBC, a Common Need Investment firm for Alzheimer's R&D, announced today that David Weild IV, Former Vice Chairman of the NASDAQ, frequently referred to as "The Father of the JOBS Act," will join the company as Co-founder & Vice Chairman of its board of directors."
"Researchers from Rutgers University gave mice small amounts of both caffeine and EHT. Individually, each compound had no effect, but combined, they activated the portion of the rodents' brains that fights the build-up of proteins that cause Parkinson's disease and Lewy body dementia."
"The study conducted at the University of Helsinki and the University of California, found that the use of two memory tests assessing episodic memory made the diagnosing of mild cognitive impairment due to Alzheimer's disease more precise. Memory tests helped identify those individuals with an increased risk of receiving an Alzheimer's diagnosis within the next three years."
"A new review of clinical trials advises on the best way forward. A new review of clinical trials advises on the best way forward... But are researchers on the right track with their investigations, and what would be the best treatment approach? A new comprehensive review published in the journal Neurology, and available online, addresses these questions."
"Axovant Sciences' ( AXON ) investigational drug Nelotanserin for the treatment of REM sleep behavior disorder in patients with Lewy body dementia has failed in a phase II trial, sending the shares down over 27%."
"The number of deaths from dementia has increased by 148% over the same 26-year period. Dementia is now the fifth most common cause of death worldwide and the second most common -- after coronary heart disease -- among people aged 70 or older."